 |
¹ Dual NRTI
combination recommendations: Strongly recommended choices: Zidovudine plus
didanosine or lamivudine; or stavudine plus lamivudine. Alternative choices:
Abacavir plus zidovudine or lamivudine; or didanosine plus lamivudine. Use
in special circumstances: Stavudine plus didanosine; or zalcitabine plus
zidovudine. Insufficient Data: Tenofovir- or emtricitabine-containing
regimens. Not Recommended: Zalcitabine plus didanosine, stavudine, or
lamivudine; or zidovudine plus stavudine
² Amprenavir should not be administered
to children under age 4 years due to the propylene glycol and vitamin E
content of the oral liquid preparation and lack of pharmacokinetic data in
this age group
|
